At the intersection of neuroscience excellence and publishing innovation stands Genomic Press, where scientific advancement meets worldwide dissemination. Our journals are premier venues for neuroscience and behavioral research, with over 100 publications guided by Editorial Boards that include a Nobel laureate and members of prestigious national academies. As an academic-driven enterprise, created by researchers for researchers, we are fully committed to scientific integrity and scholarly impact. Through our dynamic partnership with EurekAlert! (AAAS) and sophisticated digital outreach, our published work has resonated across over 1,000 media outlets in more than 15 languages worldwide. Our authors experience a publishing journey that combines scholarly rigor with contemporary efficiency. At Genomic Press we don't just publish research, we amplify scientific excellence for the global community. For updates on our journals' progress and latest developments, please visit the News section.
As part of our commitment to excellence, we provide detailed and comprehensive guidelines across all our journals. Whether you are submitting research articles, reviews (including systematic reviews), commentaries, news & views, correspondence, or other manuscript types, our unified Author Instructions offer invaluable support. By streamlining the submission process, we make it more user-friendly. Join us in advancing scientific knowledge and shaping the future of research. For further details, please go to Author Instructions.
Our Open Access model will ensure that the vital insights you uncover are made widely available, breaking down barriers in knowledge exchange and maximizing the impact of your work.
More detailed information about each journal, including submission guidelines and editorial policies, will be available soon. Please stay tuned and visit each journal’s dedicated webpage through the links below for further updates.
At Genomic Press, we eagerly anticipate sharing these new platforms for scientific dialogue and discovery. Join us as we embark on this exciting journey, charting new territories in genomic psychiatry and psychedelic pharmacology.
A new era of scientific publishing has begun!
Thank you for visiting Genomic Press. We are thrilled about the journey ahead and eager to share our progress. As we continue to evolve and prepare for the launch of our first journals, we invite you to stay tuned for exciting developments. Together, we will advance the field of neuroscience, bridging the gap from genetic intricacies to societal impacts.
THE BEST IS YET TO COME!